RHO and cancer: As Rho family of GTPases are key player in lymphocyte development and activation, and cancer cell exploiting one of their family member (ROCK1) to escape immune activity is similar to hijacking of macrophage‐produced complement C1q to promote their own tumor growth (Roumenina et al, 2019).